- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Sun Pharma Advanced Research Company confirmed full compliance with disclosure norms amid recent unusual trading volumes. It assured that no undisclosed price-sensitive information is pending and emphasized its commitment to transparent, timely updates to stock exchanges. This reassures shareholders about the company’s adherence to transparency and governance standards.
All announcements from Sun Pharma Advanced Research Company Limited